SRRM2 and Miyoshi myopathy: This study aimed to use flow cytometry to detect the expression of SRRM2 on plasma cells in plasma cell disorders, particularly MM, and to explore whether SRRM2 protein can serve as a biomarker for MM and a potential target for immunotherapy.